Literature DB >> 16565097

Evaluating new screening tests for breast cancer.

Les Irwig, Nehmat Houssami, Bruce Armstrong, Paul Glasziou.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16565097      PMCID： PMC1410890          DOI： 10.1136/bmj.332.7543.678

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  13 in total

1.  Breast cancer screening with MRI--what are the data for patients at high risk?

Authors:  Laura Liberman
Journal:  N Engl J Med       Date:  2004-07-29       Impact factor: 91.245

2.  Breast MRI for women with hereditary cancer risk.

Authors:  Mark E Robson; Kenneth Offit
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

3.  What should the burden of proof be for acceptance of a new breast-cancer screening technique?

Authors:  Martin J Yaffe
Journal:  Lancet       Date:  2004 Sep 25-Oct 1       Impact factor: 79.321

4.  Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study.

Authors:  Sophia Zackrisson; Ingvar Andersson; Lars Janzon; Jonas Manjer; Jens Peter Garne
Journal:  BMJ       Date:  2006-03-03

5.  Extra incidence caused by mammographic screening.

Authors:  R Boer; P Warmerdam; H de Koning; G van Oortmarssen
Journal:  Lancet       Date:  1994-04-16       Impact factor: 79.321

6.  Interval breast cancers in New South Wales, Australia, and comparisons with trials and other mammographic screening programmes.

Authors:  R Taylor; R Supramaniam; M Rickard; J Estoesta; C Moreira
Journal:  J Med Screen       Date:  2002       Impact factor: 2.136

7.  Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern?

Authors:  E Paci; J Warwick; P Falini; S W Duffy
Journal:  J Med Screen       Date:  2004       Impact factor: 2.136

8.  Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study.

Authors:  Per-Henrik Zahl; Bjørn Heine Strand; Jan Maehlen
Journal:  BMJ       Date:  2004-03-10

9.  Incidence of and treatment for ductal carcinoma in situ of the breast.

Authors:  V L Ernster; J Barclay; K Kerlikowske; D Grady; C Henderson
Journal:  JAMA       Date:  1996-03-27       Impact factor: 56.272

Review 10.  New technologies in screening for breast cancer: a systematic review of their accuracy.

Authors:  L Irwig; N Houssami; C van Vliet
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640
View more
  5 in total

1.  Q and a: magnetic resonance imaging in the detection and evaluation of breast cancer.

Authors:  Dana S Wollins; Mark R Somerfield
Journal:  J Oncol Pract       Date:  2008-01       Impact factor: 3.840

2.  Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy.

Authors:  Nariya Cho; Wonshik Han; Boo-Kyung Han; Min Sun Bae; Eun Sook Ko; Seok Jin Nam; Eun Young Chae; Jong Won Lee; Sung Hun Kim; Bong Joo Kang; Byung Joo Song; Eun-Kyung Kim; Hee Jung Moon; Seung Il Kim; Sun Mi Kim; Eunyoung Kang; Yunhee Choi; Hak Hee Kim; Woo Kyung Moon
Journal:  JAMA Oncol       Date:  2017-11-01       Impact factor: 31.777

3.  Hybrid design evaluating new biomarkers when there is an existing screening test.

Authors:  Yeonhee Park; Ying Yuan; Jing Ning; Suyu Liu; Ziding Feng
Journal:  Stat Med       Date:  2021-02-04       Impact factor: 2.373

4.  Chapter 10: deciding whether to complement a systematic review of medical tests with decision modeling.

Authors:  Thomas A Trikalinos; Shalini Kulasingam; William F Lawrence
Journal:  J Gen Intern Med       Date:  2012-06       Impact factor: 5.128

5.  Impact of Full-Field Digital Mammography Versus Film-Screen Mammography in Population Screening: A Meta-Analysis.

Authors:  Rachel Farber; Nehmat Houssami; Sally Wortley; Gemma Jacklyn; Michael L Marinovich; Kevin McGeechan; Alexandra Barratt; Katy Bell
Journal:  J Natl Cancer Inst       Date:  2021-01-04       Impact factor: 13.506
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.